Viewing Study NCT02086227


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-02-10 @ 2:13 PM
Study NCT ID: NCT02086227
Status: COMPLETED
Last Update Posted: 2014-03-13
First Post: 2014-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
Sponsor: Fresenius Kabi USA, LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GLUC-002-CP1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators